Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 06, 2023

SELL
$13.84 - $20.79 $326,900 - $491,059
-23,620 Reduced 25.96%
67,364 $984,000
Q2 2023

Jul 25, 2023

BUY
$10.7 - $17.48 $322,465 - $526,794
30,137 Added 49.53%
90,984 $1.55 Million
Q1 2023

Apr 18, 2023

BUY
$6.45 - $14.48 $286,876 - $644,026
44,477 Added 271.7%
60,847 $850,000
Q4 2022

Jan 12, 2023

SELL
$4.53 - $7.55 $77,567 - $129,278
-17,123 Reduced 51.12%
16,370 $108,000
Q3 2022

Oct 27, 2022

BUY
$4.97 - $7.89 $166,460 - $264,259
33,493 New
33,493 $177,000

Others Institutions Holding RCEL

About AVITA Medical, Inc.


  • Ticker RCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 25,030,900
  • Market Cap $217M
  • Description
  • AVITA Medical Inc. operates as a commercial-stage regenerative tissue company in the United States, Australia, and the United Kingdom. It offers regenerative products to address unmet medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications, including vitiligo. The company's patented and prop...
More about RCEL
Track This Portfolio

Track Assenagon Asset Management S.A. Portfolio

Follow Assenagon Asset Management S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Assenagon Asset Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Assenagon Asset Management S.A. with notifications on news.